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Background: An exponential increase in the number of systematic reviews published, and constrained resources
for new reviews, means that there is an urgent need for guidance on explicitly and transparently integrating
existing reviews into new systematic reviews. The objectives of this paper are: 1) to identify areas where existing
guidance may be adopted or adapted, and 2) to suggest areas for future guidance development.
Methods: We searched documents and websites from healthcare focused systematic review organizations to
identify and, where available, to summarize relevant guidance on the use of existing systematic reviews. We
conducted informational interviews with members of Evidence-based Practice Centers (EPCs) to gather experiences
in integrating existing systematic reviews, including common issues and challenges, as well as potential solutions.
Results: There was consensus among systematic review organizations and the EPCs about some aspects of
incorporating existing systematic reviews into new reviews. Current guidance may be used in assessing the
relevance of prior reviews and in scanning references of prior reviews to identify studies for a new review. However,
areas of challenge remain. Areas in need of guidance include how to synthesize, grade the strength of, and present
bodies of evidence composed of primary studies and existing systematic reviews. For instance, empiric evidence is
needed regarding how to quality check data abstraction and when and how to use study-level risk of bias
assessments from prior reviews.
Conclusions: There remain areas of uncertainty for how to integrate existing systematic reviews into new reviews.
Methods research and consensus processes among systematic review organizations are needed to develop
guidance to address these challenges.
Keywords: systematic review methods, evidence-based practice centers, using existing reviewsBackground
Evidence-informed decisions in health care rely on the
explicit consideration of available evidence through the
conduct of systematic reviews. In the context of exponen-
tial increase in the number of systematic reviews pub-
lished, constrained resources for new reviews, and the
increase in the need to update reviews, there is an urgent
need for detailed methods to explicitly and transparently
integrate existing reviews into systematic reviews.
Since 1997, the US Agency for Healthcare Research and
Quality (AHRQ) has supported the development of system-
atic reviews about health care through its Evidence-based* Correspondence: krobin@jhmi.edu
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unless otherwise stated.Practice Center (EPC) program. These reviews generally
address multiple questions and are conducted following
standard methods. A number of years ago, researchers from
several EPCs recognized that reviewers were increasingly
faced with decisions about whether and how to incorporate
existing systematic reviews into new systematic reviews.
This group collaborated to develop guidance for the use
of existing systematic reviews in new reviews [1]. As part
of the work in developing the EPC Methods Guide, a
workgroup was subsequently formed by the AHRQ on the
same topic, and guidance that generally reflected the prior
work was issued [2].
The guidance we provided in the EPC Methods Guide
noted the need for additional work on specific methods
for using existing systematic reviews in reviews. Ourral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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has also identified additional challenges, particularly in
grading the strength of evidence and presenting the
body of evidence when existing systematic reviews form
part of the overall evidence base in a new systematic
review.
The lack of guidance has led to variable perspectives
about and usage of existing systematic reviews across
the EPC program. In particular, uncertainty and lack of
guidance has led some EPC researchers to avoid inte-
grating existing systematic reviews within the strength of
evidence judgments and summaries in new reviews. Omit-
ting existing reviews from consideration when assessing
the strength of the evidence is unsatisfying for the EPCs
and for the audiences of our reports, as recently noted in
recent feedback by the Eisenberg Center [3]. Some EPCs
have chosen to integrate existing systematic reviews into
the strength of evidence ratings, but without guidance on
how to implement such integration, the process has been
inconsistent.
The objectives of our workgroup of EPC members,
and of this white paper, are: 1) to identify areas where
existing guidance may be adopted or adapted, and 2) to
suggest approaches and focused areas for future work and
additional guidance needs.
Methods
Key methodological steps in deciding whether and how
to use existing systematic reviews in new systematic re-
views of health care questions are illustrated in Figure 1
and in the accompanying Table 1 (adapted from Whitlock
et al. [1]). These steps include five, non-mutually exclusive
options for how existing systematic reviews might be used.
In this paper, these methodological areas were used to
classify existing guidance from other health-focused sys-
tematic review organizations and to focus the discussion
with directors and staff at EPCs. Table 1 provides defini-
tions for the key steps in Figure 1.
Guidance summary
Documents and websites from healthcare focused sys-
tematic review organizations were manually searched for
available guidance on the use of existing systematic re-
views in new systematic reviews. Where available, rele-
vant guidance was extracted and summarized for each of
the methodological steps illustrated in Figure 1.
Evidence-based practice center discussions
Individual workgroup members held discussions with
volunteer EPC members including EPC directors, associate
directors, and project managers. An interview guide, in-
cluding 11 open-ended questions, facilitated the informal
discussions. The goals of the discussions were to gather in-
sights from the experiences of EPCs in integrating existingsystematic reviews into new reviews and to identify com-
mon issues and challenges, as well as potential solutions.
Individual workgroup members conducted discussions with
15 EPC members representing 10 of 11 EPCs. A list of par-
ticipating EPC members can be found in Appendix A. Each
call was, with permission of those on the call, recorded and
then transcribed. Major themes from the interviews were
identified by workgroup members through review of the
transcripts. These themes were then compared to the exist-
ing guidance to identify areas of overlap and need.
Assessment of areas of need
Workgroup members assessed the sufficiency of cur-
rently available guidance based on the needs expressed
by EPCs. Through individual and group deliberation, the
workgroup determined which methodological steps on
the use of existing systematic reviews need additional
guidance. For each area where additional guidance is
needed, the workgroup generated suggestions for how
to develop this guidance.
Results
Guidance summary
Overall, about half of the systematic review organizations
provided some direction on the use of existing systematic
reviews in new reviews. Table 2 shows the list of organiza-
tions for which websites were manually searched. A check
mark under the area of guidance denotes a comment on
the use of existing systematic reviews, though not ne-
cessarily detailed guidance. Listed organizations with no
check marks are organizations for which guidance on
the use of existing systematic reviews was not found.
Evidence-based practice center discussions
Overall themes were identified from the discussions with
EPCs:
 EPCs most commonly used existing reviews as a
source of relevant literature and as context for the
introduction or discussion section of reviews.
 Existing reviews were most useful when key
questions and/or PICOTS-SD (population, intervention,
comparator, outcome, time frame, setting, and study
design) matched or when they addressed a specific
subquestion of the new review.
 Using existing reviews was often more resource
intensive than completing a review from scratch.
 EPCs expressed that they often did not trust aspects
of reviews conducted by others.
 When relevant and rigorous, incorporating prior
reviews into the review being undertaken by the
EPC was clearly valuable in at least two instances: 1)
allowing larger scope of the review being undertaken
without additional resources, or 2) providing
Use existing data abstraction, study-level
risk of bias assessments and/or synthesis
Use existing search
Step 3. Assess quality of
existing SR(s)
Step 4. Determine appropriate
use and incorporate existing
SR(s)












Step 5. Report methods and results






Stop. Proceed with SR of
primary evidence
Use “almost” relevant SRs to
frame and provide context
(Contextual Use)
Scan References of “almost”




Scan references, check new search
results
Figure 1 Methodological steps in using existing systematic reviews (SRs).
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of primary literature would not be feasible (for
example, existing reviews provide individual patient
data analysis or include hundreds of trials,
supplemented by author-provided data).
EPCs have used existing reviews in various ways, most
commonly as a source of relevant literature, allowing
them to reduce the extent of searching to locate primary
literature or to check completeness of primary literature
search strategies. Additionally, prior reviews are oftenused to provide context for the introduction or discussion
sections of a review. At a minimum, most EPC members
feel that it is necessary to acknowledge other systematic
reviews and to put the findings of the current review into
the context of other systematic reviews, particularly in the
case of disagreements or controversy.
EPC members noted that methods determining when
and how to use an existing review are highly dependent
on the topic and scope of the new report. There are cer-
tain instances when it may be most feasible to use an
existing review as evidence in a new review. For example,
Table 1 Definitions of terms used in Figure 1
Locate existing SR(s)
A defined and reproducible approach to efficiently identify existing
systematic reviews for possible use in conducting a newly proposed
systematic review, including updates.
Assess relevance
Methods by which existing systematic reviews identified in Step 1 can
be evaluated as to whether they are similar enough to the newly
proposed review to obviate the need for conducting one or several
steps in undertaking the newly proposed review. Relevance evaluation
considers how well the existing reviews’ research questions and
inclusion/exclusion criteria for population, interventions, comparators,
outcomes, settings, and study designs match those of the new
systematic review, and how recently existing reviews’ literature searches
were concluded. Use ‘almost’ relevant SR(s) when selecting, developing,
and/or refining questions and providing context for a newly proposed
systematic review (that is, Contextual Use) and scan references to check
new search results.
Assess quality of existing SR(s)
Methods by which relevant existing systematic reviews can be
evaluated for quality of methodological approach, using AMSTAR or
other commonly used tools, with a focus on potentially incorporating
only reviews meeting certain quality criteria into the proposed review
[4,5].
Determine appropriate use and incorporate existing SR(s)
Methods by which to determine appropriate uses for relevant, high-quality
existing systematic reviews in the proposed review. Incorporate existing
SR(s) or use information from existing systematic reviews to supplement or
supplant one or more activities that would be conducted from scratch for
the newly proposed review. Use of existing systematic reviews may
include: 1) using the existing systematic review(s)’ listing of included studies
as a quality check for the literature search and screening strategy conducted
for the new review (Scan References); 2) using the existing systematic
review(s) to completely or partially provide the body of included studies for
one or more key questions in the new review (Use Existing Search); 3) using
the data abstraction, risk of bias assessments, and/or analyses from existing
systematic reviews for one or more key questions in the new review (Use
Data Abstraction/Syntheses); or 4) using the existing systematic review(s),
including conclusions, to fully or partially answer one or more key
questions in the new review (Use Complete Review).
Report methods and results from using existing SR(s)
Standards for reporting the rationale for incorporating existing
systematic reviews and the methods by which specific existing
systematic reviews were located, assessed, and incorporated into the
current systematic review. Standards for reporting results in the current
systematic review that rely on evidence and/or analysis from existing
systematic reviews and caveats or limitations associated with that
approach; guidance about discussing how findings of the current
systematic review compare and contrast with those of existing relevant
systematic reviews.
AMSTAR, A Measurement Tool to Assess Systematic Reviews; SR,
systematic review. Adapted from Whitlock et al. [1].
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a new review when the key questions match and when the
review questions are concerned primarily with one or a
few clearly and specifically defined and measured out-
comes; existing systematic reviews are fruitful to incorpor-
ate to answer contextual questions that do not demand a
full systematic review, but are important for decision
makers when considering the evidence base. Conversely,
EPC members indicated there are other instances when itwould not make sense to use an existing review, such as
when there are few studies on a given topic or when there
are multiple conflicting systematic reviews. When incorp-
orating existing reviews into a new or updated review,
EPC members most often described qualitative or narrative
incorporation of the existing reviews, noting that quantita-
tive combination of findings (without going back to all pri-
mary studies) is more difficult and potentially introduces
error, and thus, is less commonly done.
EPC members varied in their thoughts and experiences
about the efficiency of incorporating existing reviews into
new reviews. Most thought that, although this process
theoretically should result in efficiency gains, challenges
that arise when trying to use reviews often negate any in-
creased efficiency. These challenges arise from the need to
understand and qualify the methods for existing system-
atic reviews as intensively as primary studies. Thus, EPC
members often described experiences where using a prior
systematic review resulted in as or more intensive resource
requirements as completing a new review of primary litera-
ture. A particular concern were instances in which stake-
holders who nominated the review requested a new review
after seeing the results of incorporation of existing reviews.
It is hard to estimate how much work will be required to
clarify the relevance or quality of existing systematic re-
views, since effort depends on the volume of existing sys-
tematic reviews, as well as issues specific to the match
between existing reviews and the review being undertaken;
these include whether the key questions are an exact
match or how the existing systematic review authors
approached important methods, such as strength of evi-
dence grading or risk of bias assessment. In a number
of cases, EPC members described eventually having to
conduct much of the process from scratch in spite of
completing the additional step of in-depth examination
of existing reviews. EPC members voiced concern about
using this process based on the potential (although
often unrealized) benefit of efficiency, while running an
unclear risk of error or reduced quality from relying on
unverifiable work from others. Additionally, EPC mem-
bers described discomfort with the lack of guidance in
this area, noting inconsistency across EPCs in how this
process is approached and hesitancy to engage in such
a process without explicit direction in the EPC Methods
Guide.
Although EPC members felt that it was often difficult
to gain efficiency incorporating existing reviews in new
reviews, they acknowledged other potential benefits to
this process. Some described that including existing re-
views sometimes enables them to cover a wider range of
questions and elements of questions (as denoted by PI-
COTS) when existing systematic reviews address import-
ant aspects of new review key questions. EPC members
suggested that this breadth is often desirable, but may































AHRQ Evidence-based Practice Center Program
(EPC program)
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Methods Guide for Effectiveness and Comparative
Effectiveness Reviews [2]
Reporting the Findings of Updated Systematic
Reviews of Comparative Effectiveness [6]
✓
Canadian Agency for Drugs and Technology in
Health (CADTH)
Guidelines for Authors of CADTH Health
Technology Assessment Reports [7]
Cochrane Collaboration ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Cochrane Handbook for Systematic Reviews of
Interventions [8]
Danish Centre for Health Technology
Assessment (DACEHTA)
✓ ✓ ✓
Health Technology Assessment Handbook [9]
European Collaboration for Health Technology
Assessment (ECHTA)
✓ ✓ ✓
Best Practice in Undertaking and Reporting Health
Technology Assessments [10]
Health Technology Assessment International
Institute of Medicine
Finding What Works in Health Care: Standards for
Systematic Reviews [11]




National Institute for Health and Care
Excellence (NICE)
✓ ✓ ✓ ✓
The Guidelines Manual, Draft for Consultation [13]
York Centre for Reviews and Dissemination:
Systematic Reviews (CRD)
✓ ✓ ✓
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erature is required due to time and resource limitations.
Similarly, important evidence to answer some key ques-
tions may include individual patient data meta-analyses
or data from a large number of trials, representing work
from systematic reviewers that would be very difficult or
impossible to reproduce.
Overall, EPC members noted that more guidance is
needed for using existing reviews in new systematic re-
views. Most felt that detailed, specific, step-by-step guid-
ance may not be feasible, but that some further articulation
of important areas to consider, with clear worked examples,
would be helpful. Commonly highlighted areas in need of
additional guidance include:
1. Providing principles or criteria for when a new
review adds value to a field with many existing
reviews.
2. Providing templates or advisory considerations for
construction of evidence tables for reviews
combining primary and secondary (systematic
review-level) evidence.
3. Reporting guidelines for clearly communicating the
methods for locating, selecting, and deciding how
best to utilize existing systematic reviews.
4. Methods that limit the potential for bias in selecting
reviews to incorporate from among multiple existing
reviews.
5. Guidance on methods that limit the potential for
bias in incorporating selected portions of a
review.
6. Qualitative and quantitative methods for
summarizing bodies of evidence that include a
systematic review as the only or as one source of
evidence.
7. More robust means for quality rating of existing
systematic reviews (beyond AMSTAR [4]).
8. Specific methods to grade strength of evidence
for bodies of evidence that include a systematic
review as the only or as one source of evidence.
Guidance addressing the first item listed is more of a
scoping question prior to the initiation of a new review
(for example, within the Topic Refinement stage of the
EPC program’s current processes). In this paper, we as-
sume that a new review has been started and is the review
authors are considering incorporating existing reviews.
The remaining challenges in using existing reviews are
discussed below and fall within each of the methodological
areas presented in Figure 1. A summary of the existing
guidance for each area is presented along with an as-
sessment of future guidance needs.Discussion
Methodological areas: assessment of areas of need
Locating existing systematic reviews
Available guidance Several organizations present guid-
ance on locating existing systematic reviews, including the
EPC program and the Cochrane Collaboration (see Table 3).
These groups recommend using specific databases and
search filters to aid in locating existing systematic reviews.
Commonly recommended databases include: Database of
Abstracts of Reviews of Effects (DARE), Cochrane Data-
base of Systematic Reviews (CDSR), Health Technology
Assessment Database, MEDLINE and Embase. Some or-
ganizations promote limiting searches for existing system-
atic reviews to selected sources (for example, CDSR), with
the idea that these systematic reviews would be expected
to meet sufficient quality standards. We identified no cri-
teria for selecting systematic reviews.
Evidence-based practice center discussions EPC mem-
bers expressed concerns about locating reviews based on
very limited sources, for example, only searching for EPC
or Cochrane reviews. Some EPC members were uncom-
fortable with any type of selective search instead of doing
a broader, if not comprehensive, search for existing sys-
tematic reviews. However, other EPC members felt it
could be appropriate to selectively use one or two earlier
reviews without having to review all of the available prior
reviews, pointing out that the scientific rationale and pur-
pose in conducting a systematic search for existing system-
atic reviews is different than when searching for primary
studies. Currently, there is a lack of consensus and limited
guidance concerning how to adequately locate and trans-
parently select and use only a subset of reviews.
Assessment Current EPC guidance on locating existing
systematic reviews states that EPCs should conduct a
targeted search of a higher yield database, which in-
cludes output from the EPC program, MEDLINE’s Top
120 Index Medicus Journals, Health Technology Assess-
ments, CDSR and DARE. EPC program guidance sug-
gests that identifying existing systematic reviews may be
done separately or be completed as part of the broad
search for primary literature to answer key questions.
EPC members shared concern about the extensive effort
that may be required to search for and locate all reviews
and assess their quality. Instead, given the purpose of lo-
cating existing systematic reviews, the ideal search might
locate only highly relevant, well-done, very recent, exist-
ing systematic reviews that are more likely to allow the
current reviewer to leverage the prior work. Some mem-
bers proposed that future guidance further limit the search
for earlier reviews to sources that may have greater likeli-
hood of identifying higher quality and better reported re-
views, such as the EPC and Cochrane databases. This
Table 3 Guidance summary
AHRQ Evidence-based Practice Center Program (EPC program) Cochrane collaboration Danish Centre for Health Technology
Assessment (DACEHTA)
Locating Two strategies are recommended for identifying existing systematic reviews for a CER. The
first strategy is to perform a targeted search of a higher yield database, which includes
output from the Evidence-based Practice Center program, MEDLINE’s Top 120 Index Medicus
Journals, Health Technology Assessments, Cochrane Database of Systematic Reviews and Data-
base of Abstracts and Reviews of Effects. The second strategy is to identify systematic reviews
during a broad de novo literature search.
Systematic reviews can be located through
CDSR, DARE and HTA database. MEDLINE and
EMBASE can also be used to search for
systematic reviews. In MEDLINE, most review
articles can be found under the publication
Term ‘Meta-analysis’ and in EMBASE, the
thesaurus term ‘Systematic Review’ can be
used. Specific search strategies can be used to
identify systematic reviews in MEDLINE and
EMBASE. Additionally, systematic reviews can
be identified through search services such as
Turning Research into Practice (TRIP).
Secondary studies (for example, systematic
reviews, HTA reports, and clinical guidelines)
should be located to determine if key
questions have already been answered.
Secondary studies can be identified through
several databases (for example, The HTA
Database, Cochrane Database of Systematic
Reviews, Database of Abstracts of Reviews of
Effects, Guidelines International Network,
National Guidelines Clearinghouse, Health
Evidence Network, National Electronic
Library for Health: Guidelines Finder, and
Turning Research Into Practice).
In an Overview, primarily only Cochrane
Intervention reviews should be included, but
other reviews may be included occasionally
Assessing
Relevance
An existing systematic review should be used with the intent to answer parts or all of
specific key questions. PICOTS-SD must be considered for relevance of existing systematic
reviews. Reviews that are partially relevant may be useful for background or checking
references. An initial screening for relevance should be performed, considering the
timeliness of the review’s literature search. It is recommended to bridge any search date
that ended more than one year from the time the systematic review is identified. If a
review is outdated but still desired to be used, an update of the search should be done.
In an Overview, included reviews should be
assessed using specific criteria.
Considerations include whether a review is
up-to-date and if there are specific limita-
tions for the objectives of the Overview.
All evidence should be assessed for relevance to
the topic. Identified articles should be compared
to the focused question to determine if the
article may answer the focus question. The
literature can be divided into two groups
(secondary studies and primary studies). If a large
amount of evidence has been identified, it can
be subdivided into groups based on presumed
quality. The hierarchy of evidence is: 1) meta-
analyses and systematic reviews (among others
Cochrane reviews); 2) randomized controlled
trials (RCTs); 3) non-randomized controlled trials;
4) cohort studies; 5) case-control studies; 6)
descriptive studies, limited series; and 7) position
papers, non-systematic reviews, leading articles,
expert opinions.
In the second stage of screening, the review’s PICOTS-SD elements should be compared to
those in the new review protocol for relevance. If these elements are poorly reported, the




Only reviews of high quality should be included in a CER. Two independent reviewers should
assess for quality and methods for resolving discrepancies should be reported. A quality rating
instrument should be used to addresses all aspects of the review that will be incorporated
into the CER. Both the methods used to minimize bias and the reporting should be assessed.
QUOROM (PRISMA) is a checklist that can be used to assess the reporting of systematic
reviews. As a common starting point, the AMSTAR tool should be used to assess the quality of
reviews. Reproducibility and application of inclusion and exclusion criteria should be
confirmed. As some limitation to AMSTAR exists, it is recommended to describe implications
of potential methodological flaws instead of relying on numerical scores.
Generally, selection criteria for a Cochrane
Overview limits included reviews to
Cochrane reviews. Non-Cochrane systematic
reviews may be included if there are good







The list of included articles from an existing review can be used in a CER if methods for
identifying articles are of adequate quality.
Existing systematic reviews can be used as
sources of relevant studies. References lists of
systematic reviews can be searched to identify
relevant articles. This should be done as an
adjunct to other search methods as bias may

























Part or all of the search strategy may be used from an existing review if it is consistent
with EPC program methods for finding evidence. A search strategy from an existing review
can be used, followed by de novo analysis and synthesis of data.
Existing reviews may be a useful sourc






In order to use the risk of bias assessment from a systematic review, the methods used
must be consistent with the EPC program methods guide. These methods include
selection of design specific criteria for risk of bias assessment and use of appropriate tools.
In an Overview, an assessment of the lity
of evidence should be done. If no
assessment was done in an included
systematic review, authors should perf
the assessment. If a quality assessmen as
done in an included systematic review
authors should assess the judgments a
ensure consistency between included
reviews.
A quality assessment tool should be used to
uniformly assess the quality of identified
articles. Check list tools developed by
different national centers (for example, SIGN,
NICE, GRADE and Centre for Evidence-based





The data extraction tables may be used from an existing review, if they are deemed to be
of adequate quality. However, if results of individual trials are not reported, the use of
summary findings from an existing review may compromise transparency for a CER and
this is not recommended.
In an update, data from new studies s ld
be abstracted and included, if applicab
No guidance
In an Overview, if necessary, authors m
seek additional data or information fro the




If an existing review is very similar to a CER in research questions and is high quality, the
entirety or portions of the existing review may be incorporated. Summarized evidence for
specific populations or interventions may be included in a CER. If summarized evidence is
to be included, the existing review must have methods consistent with EPC program
methods for finding evidence, assessing quality, grading the strength of evidence and
other principles including conflicts of interest. Summarized evidence can also be
incorporated with a de novo sensitivity analysis.
In an update, data collected from new
studies should be included and a new
meta-analysis should be done.
No guidance
If multiple high quality reviews are found, a single review can be chosen, which is most
relevant and least biased, or a meta-review can be performed.
In an Overview, authors should reply o
previous analyses when possible. If the are
differences between reviews (for exam ,
different populations or subgroups are
analyzed), data may need to be reanal d.
If more than one high quality review is found with discordant findings, it may be an




It is recommended to provide a summary table to show where existing review(s) were
used to replace de novo processes. Summary tables of existing systematic reviews should
be included to compare the reviews and should address any overlap (or lack thereof) in
the primary research included in reviews.
In an update, revision to text of the exis
review will depend on the influence of
new data and results. If there is no chan in
the results, little revision to the text is
required. However, some updates may uire
a change to the conclusion of a review ich
will require much modification of the te It
should be noted in the Abstract and
Background that this is an update. A ‘W ’s
new’ table should be completed and ch ges
should be made to ensure no dates or er
information is out of date.
No guidance
The discussion section should include a justification for using an existing systematic review
and address any limitations. It is also important to compare findings from the CER with the
findings from existing reviews.
In an update, it is important to show explicitly what has changed from the previous report.
The desired depth of information varies between users of reports. Review updates may be
effectively presented in an executive summary with tables and figures, identifying and










































Table 3 Guidance summary (Continued)
European Collaboration Health
Technology Assessment (ECHTA)
Institute for Quality and Efficiency in
Health Care (IQWiG)
National Institute for Health and Cli al
Excellence (NICE)
York Centre for Reviews and
Dissemination: Systematic Reviews (CRD)
Locating In order to determine if key questions have
already been answered, a search for
previous HTA reports should be conducted.
The search for previous reports should be
systematic and well documented.
Different databases should be considered in
locating systematic reviews that are used for
primary literature. Databases that exclusively
or mostly hold systematic reviews should be
searched as well as biomedical databases
(for example, MEDLINE and EMBASE), which
also hold systematic reviews.
Core and subject databases, including
MEDLINE, EMBASE, Cochrane Database
Systematic Reviews, Database of Abstr s of
Reviews of Effects, Cochrane Central Re ster
of Controlled Trials, and Health Techno y
Assessment (HTA) database, should be
searched for every review. For question on
effectiveness, a search should be done r
systematic reviews, followed by random ed
controlled trials, then cohort or case–c trol
studies. Search filters are available to a t
in identifying studies, including a searc
filter for systematic reviews.
To check if key questions have been answered
by existing or ongoing reviews, a search for
systematic reviews should be conducted. The
Database of Abstracts of Reviews of Effects
(DARE), and the Cochrane Database of
Systematic Reviews (CDSR) should be
searched. Additionally, NICE and NIHR HTA
program Websites can be searched along with
the Campbell Library of Systematic Reviews
and the Evidence for Policy and Practice
Information Centre’s Database of Systematic
and Non Systematic Reviews of Public Health
Information (DoPHER). Guideline groups
including NGC and SIGN can be searched for
guidelines based on systematic review
evidence. MEDLINE and other databases can
be searched for previous reviews.
Evidence scanning should be done
continuously to identify systematic reviews
that concern published or developing
information products. Two people should
regularly screen (CDSR, DARE, INAHTA, MORE
and PubMed). Identified reviews that concern
a product of the Institute can influence the
updating process, including triggering an
update or modifying the updating plan.
Assessing
Relevance
All identified evidence should be assessed
with pre-defined inclusion and exclusion cri-
teria. Selection criteria should be developed
from background information, research
questions and the availability of evidence
and should be defined prospectively to
avoid bias in selection of evidence. Inclusion
and exclusion criteria should cover patient
characteristics, condition characteristics,
technology aspects, methodological issues,
outcomes measured, publication type.




No guidance For systematic reviews to be used in a benefit
assessment, they must be assessed for sufficient
quality. They must ‘show only a minimum risk
of bias; present the evidence base in a
complete, transparent and reproducible
manner; and thus allow clear conclusions to be
drawn’. The searches conducted in the
systematic reviews must not contradict the
methodology of the Institute. Quality
assessment should be done with Oxman and
Guyatt’s quality index for systematic reviews or
AMSTAR. Sponsors and authors’ conflicts of
interests should be documented and discussed
for systematic reviews.
Guidelines may contain reviews of evide e
that are applicable to questions formula by
the guideline development group. Thes ay
be used as evidence if: ‘they are assesse
using the appropriate methodology che list
from this manual and are judged to be
high quality, they are accompanied by a
evidence statement and evidence table the
evidence is updated according to the
methodology for the exceptional updat f
NICE clinical guidelines’.
Identified reviews should be assessed for
quality. Quality reviews should have a well-
defined question, comprehensive search, clear
and appropriate selection or studies, unbiased
processes for assessing study quality and
extracting and synthesizing data. Checklists
can be used to help in assessing quality of
systematic reviews (for example, Oxman and







































Table 3 Guidance summary (Continued)
If more than one systematic review of
adequate quality is found to address a
particular subject, additional quality assessment
should be done. Items to compare include:
content of the review, search strategy and
date, sensitivity analysis, how bias is assessed





No guidance No guidance No guidance Other sources of literature include
references lists of systematic reviews.
References lists of existing reviews can be
scanned to identify additional studies.
Determining
use: Search





All evidence should be critically assessed for
quality. Checklists can be used for appraisal
of medical literature. All sources of
information should be appraised for validity.
No guidelines exist for assessing quality of
sources of information other than medical
literature, and this is a gap that future
guidance needs to address.




No guidance No guidance If using reviews of evidence published in
other guidelines, the guideline development
group should create new evidence
summaries or statements. The original
evidence tables should be referenced with a
direct link to the source if possible or a
reference to the published document.
Verbatim quotes of recommendations from
other guidelines should not be used, unless










No guidance Results of systematic reviews should be
summarized in tables if possible. If
discordant results on the same outcome are
found, possible explanations should be
given. If it appears that a new benefit
assessment based on primary studies would
produce different results, a new assessment
should be done.
Original evidence tables from published
guidelines should be referenced with a
direct link to the source if possible or a
reference to the published document.
Verbatim quotes of recommendations from
other guidelines should not be used, unless
the recommendations come from NHS
policy or legislation.
No guidance
CDSR, Cochrane Database of Systematic Reviews; CER, comparative effectiveness review; DARE, Database of Abstracts of Reviews of Effects; DoPHER, Database of Systematic and Non Systematic Reviews of Public
Health Information; GRADE, Grading of Recommendations Assessment, Development and Evaluation; INAHTA, International Network of Agencies for Health Technology Assessment; MORE, McMaster Online Rating of
Evidence; NIHR, National Institute for Health Research; NGC, National Guide Clearinghouse; NHS, National Health Service; NICE, National Institute for Health and Care Excellence; PICOTS-SD, population, intervention,
comparator, outcome, time frame, setting, and study design; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; QUOROM, Quality of Reporting of Meta-analyses; SIGN, Scottish
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report is a systematic review.
Assessing relevance
Available guidance Several organizations present guid-
ance on assessing the relevance of existing systematic re-
views. European Collaboration for Health Technology
Assessment (ECHTA) and Danish Centre for Health Tech-
nology Assessment (DACEHTA) provide general guidance
for assessing the relevance of all literature, but no guidance
specific to existing reviews. Cochrane provides guidance for
assessing the relevance of existing systematic reviews for
use in an overview of reviews and specifically recommends
that reviewers consider if a review is up-to-date (up-to-date
is not defined in this context, but for Cochrane reviews is
considered as a review with a search conducted within last
2 years). The EPC program provides EPCs with some guid-
ance for assessing whether an existing review can answer
key questions or sub-questions of a review. The EPC
program recommends consideration of how recently the
review’s primary literature search ended and how well the
PICOTS-SD elements are reported and match with the
current review, noting that partially relevant reviews may
be useful for background or checking references. As de-
scribed in Table 3, specific steps recommended in EPC
guidance include conducting an initial screening for rele-
vance while considering the timeliness of the review’s lit-
erature search. In the second stage of screening, the
review’s PICOTS-SD elements should be compared to
those in the new review protocol for relevance. If these
elements are poorly reported, the new reviewers should
not consider incorporating the existing review. If a re-
view is outdated, but otherwise on point, an update of
the search could be done.
Evidence-based practice center discussions EPC mem-
bers raised concerns about deciding which existing reviews,
if any, to use in a new review, especially in situations when
many reviews of varying quality or scope are available. It
can often be difficult to find reviews that match all ele-
ments of question. Still, existing reviews may be sufficiently
similar to consider using, although criteria for all situations
are not easy to define. Thus, determining which reviews
are ‘close enough’ is inherently subjective and can be time
consuming.
Assessment Guidance exists for assessing the relevance of
existing reviews for conducting overviews of reviews and
for integrating existing reviews into a new review. Even so,
EPC members expressed concerns about selecting which
reviews to use when many are available. They reported
rarely finding reviews that match directly all elements of
questions. A clearer understanding of the factors (such as
clinical area, review purpose, volume of literature, type ofreview) that have been correlated with successful (and un-
successful) attempts to incorporate prior systematic reviews
into new reviews would be helpful.
Assessing review quality
Available guidance Guidance is available on assessing the
overall quality of systematic reviews (see Table 3). ECHTA
and DACEHTA provide general guidance for assessing the
quality of all literature, but do not specifically address asses-
sing the quality of systematic reviews. In contrast, Institute
for Quality and Efficiency in Health Care (IQWiG) and
York Centre for Reviews and Dissemination (CRD) present
guidance on assessing the quality of systematic reviews and
recommend the use of a quality rating tool or checklist
such as Oxman and Guyatt’s quality index or the AMSTAR
Instrument [4,5]. NICE suggests using existing reviews as
evidence in developing a new guideline if they are up-to-
date, have been assessed as high quality using the NICE
methodology checklist for systematic reviews [15], and in-
clude the accompanying evidence statements and evidence
tables. EPC guidance recommends using AMSTAR as a
starting point for quality assessment and supplementing as
deemed appropriate for specific reviews. The Cochrane
Collaboration is currently developing a new tool (ROBIS)
to assess risk of bias in systematic reviews. In addition, the
IOM report Finding What Works in Health Care: Stan-
dards for Systematic Reviews may provide the basis for the
development of instruments to assess quality of systematic
reviews [11].
Evidence-based practice center discussions EPC
members raised concerns about using AMSTAR to rate
the quality of reviews, specifically, as to how accurate
AMSTAR is in differentiating between poorer quality
and better quality reviews. This is important since EPCs
generally agreed that evidence from existing reviews
should only be used if the review can be relied upon to
substitute for the methods for the conduct of reviews es-
poused by the EPC program. A suggestion was raised for
a minimum standard of quality to be set for earlier re-
views that are included as evidence in new reviews.
Assessment Guidance is available for quality rating of
reviews with available tools and checklists (for example,
Oxman and Guyatt, AMSTAR, and National Institute
for Health and Care Excellence (NICE)) [5,15,16]. How-
ever, EPC members noted that these quality assessment
tools have limitations. Further, it is important to remem-
ber that these instruments do not assess the quality of
primary evidence, which must also be taken into
consideration. More explicit consideration of the quality
rating approaches available for systematic reviews, and
empiric evidence to support these, would help in the
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views for use in new reviews.
Determining appropriate use for relevant existing
systematic reviews: scanning references
Available guidance Cochrane, the EPC program, and
CRD provide guidance on scanning the reference lists of
existing systematic reviews (see Table 3). These organi-
zations suggest scanning the reference lists of existing
reviews as a supplementary method to find relevant
studies for a new systematic review. Prior EPC program
guidance suggested cross-checking primary studies from
one or more existing systematic reviews to confirm ad-
equacy of primary searches or to help select the most
comprehensive existing review for incorporation.
Evidence-based Practice Center Discussions Overall,
most EPC members had experience using existing re-
views for scanning references for relevant articles. No
major concerns over the use of existing reviews in this
manner were presented.
Assessment Some guidance is available for using exist-
ing reviews as a potential source of relevant studies for a
new review. As noted below, incorporating search results
from a prior systematic review to substitute for some or
all of the new review’s search efforts is different from
simply scanning references as an additional source of in-
formation to support other efforts. More commonly, the
latter occurs (that is, reference lists from existing reviews
are used to augment or check comprehensiveness of the
search yield used in the current review). In general, EPC
members felt comfortable using existing reviews as a
way to identify possible additional articles for a review.
Thus, this does not appear to be an area where future
guidance is needed except for the general methodo-
logical question of when this type of hand-searching has
reached saturation (that is, when no further relevant
studies are being identified and searching may stop).
Determining use: search strategy and results of existing
searches
Available guidance Cochrane and the EPC program pro-
vide guidance on using the search strategy from existing re-
views (see Table 3. The EPC program recommends using
part or all of the search strategy from an existing review,
particularly in the case of updating. The EPC program also
indicates when it is acceptable to incorporate results of
searches from existing systematic reviews to locate all pri-
mary studies - that is, when the search methods (for
example, search strategy, inclusion/exclusion criteria, litera-
ture screening methods) are consistent with EPC program
methods for finding evidence. The EPC program recom-
mends supplementing primary studies from the existingsystematic review by performing bridge searches whenever
the search date for the existing review ended more than
1 year earlier than searches for the new review are being
conducted [2]. Data from primary studies gathered through
these combined search efforts are then abstracted, followed
by a new analysis and synthesis of data. Cochrane recom-
mends utilizing information about search strategies from
existing reviews and guidelines when possible in a new re-
view, but does not address using search results in entirety.
Evidence-based practice center discussions EPC mem-
bers reported sometimes using the search strategy from
an existing review, particularly when search strategies
are reviewed and approved as robust by their medical
librarians. EPCs also mentioned that, once they have
determined it is methodologically appropriate to incorpor-
ate an existing review’s search results, they go beyond sim-
ply including the primary studies from the existing search.
Instead, they check the primary studies against their inclu-
sion/exclusion criteria, and some go further by also checking
all studies from the excluded studies table in the previous
systematic review, particularly in cases where there are
slight differences in the questions or eligibility criteria.
Assessment Some guidance is available on using the search
strategy and search results from existing reviews. The EPC
program provides some guidance for when to trust a
search strategy from a prior review. Given the developing
practice of requesting peer review for their search strat-
egies, medical librarian review prior to incorporating an
existing search strategy could be warranted [2]. Existing
guidance related to when and how to incorporate the re-
sults of previous search strategies is relatively robust in
the current EPC guidance; incorporation of existing search
results is also the most common way EPCs report incorp-
orating existing systematic reviews into their work. Fur-
ther guidance should be based on empiric evidence to
establish whether any additional value is added by 1) con-
sidering included studies from more than one existing sys-
tematic review and 2) considering excluded studies from
the previous systematic review upon which the search re-
sults are being based.
Determining use: data abstraction
Available guidance Cochrane, NICE, and the EPC pro-
gram provide guidance on using the data abstraction
from existing reviews (see Table 3). When using existing
reviews in a new guideline, NICE recommends creating
new evidence summaries but using and directly referen-
cing the original evidence tables from the prior review.
For an overview of reviews, Cochrane guidance recom-
mends using the abstracted data presented in the exist-
ing reviews and seeking additional information from the
authors of systematic reviews or from primary study
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in this area such as the Systematic Review Data Reposi-
tory (SRDR) project, which will likely affect how ab-
stracted data are used in the future, current guidance
from the EPC program suggests using data abstraction
tables from an existing review only if the methods used
are deemed to be high quality and consistent with the
EPC program methods for abstracting evidence.
Evidence-based practice center discussions Most EPC
members had concerns over whether or not data abstracted
from an existing review are trustworthy, comprehensive, or
accurate. Additionally, it was often reported that people
tend to have to go back and abstract at least some data
themselves from the primary studies due to slightly differ-
ent outcomes, missing data or improper abstraction. This
is particularly true when access to full evidence tables is
limited, as can be the case with some peer-reviewed arti-
cles. For any data abstraction that is incorporated, spot-
checking for quality assurance was recommended, though
there was no consensus on the minimum level required.
Assessment Some guidance is available for using the
data abstraction from existing reviews. However, there
are still issues to be resolved when considering using ab-
stracted data from an existing review. Additionally, on-
going work such as the SRDR project could obviate the
need for separate guidance if pre-abstracted, high-quality
data become available for many reviews. At the least,
tools like SRDR will result in the need for updated guid-
ance which incorporates such new data resources for re-
viewers. Guidance should specifically address various
possible data abstraction scenarios. One such example is
guidance related to including all versus only some of the
abstracted data from an existing review. Because of differ-
ent review scopes, PICOTS-SD, quality criteria of included
studies, etcetera, systematic reviewers may determine that
they will only need to use a portion of the data included in
an existing review. Conversely, systematic reviewers may
need to add to existing abstracted data either by abstract-
ing additional data from previously included studies or by
adding entirely new studies. Finally, as noted in the EPC
discussion themes, systematic reviewers are often con-
cerned about the trustworthiness or accuracy of abstracted
data. Therefore, guidance is needed to establish consistent,
reliable methods for conducting data checking or confirm-
ing the abstracted data to assure accuracy.
Determining use: study-level risk of bias assessments
Available guidance Guidance is available on assessing the
risk of bias of individual studies, though little guidance spe-
cifically addresses how to incorporate this information from
existing reviews into a new systematic review. AS noted in
Table 3, Cochrane recommends conducting qualityassessments of evidence for all outcomes addressed in an
overview of reviews and evaluating the quality assess-
ment judgments from existing reviews to ensure
consistency among included reviews. If an existing re-
view does not include a quality assessment, Cochrane
recommends performing a quality assessment of the
primary studies.
Evidence-based practice center discussions EPC mem-
bers noted that quality assessment of a systematic review to
determine appropriateness for inclusion in a new systematic
review is not sufficient to represent the quality of individual
studies included in the existing review. When a review is in-
corporated as more than a source of primary studies, it
raises a number of issues about how to proceed in terms of
quality rating. EPC members expressed strong concerns
about relying on the risk of bias assessments from prior re-
views; in particular, risk of bias assessments are known to
be poorly reproducible, and often lack transparency and ra-
tionale for ratings. No guidance is available on how to inte-
grate information from reviews that do not have risk of bias
assessments, or used risk of bias assessment tools different
from those used in the new review. Overwhelmingly, EPC
members felt that the primary studies included in an earlier
review needed to be quality rated in some way that is suffi-
ciently consistent with that applied to newly identified pri-
mary studies included in the new review. Even if existing
reviews include risk of bias assessments, an overarching
theme from the discussion with EPC members was that it
may be difficult for reviewers to trust the reliability of
other reviewers’ risk of bias assessments. Some EPC mem-
bers felt that you may be able to trust particular sources
(for example, Cochrane or EPCs) using particular risk of
bias assessment tools.
Assessment Guidance is readily available for assessing
the risk of bias of primary studies with currently available
tools and checklists (for example, Cochrane, EPC pro-
gram) [2,8,17,18]. However, the lack of guidance about
when to accept or when to repeat such assessments when
conducted by others as part of prior reviews was of par-
ticular concern to EPCs. Other issues of concern for EPCs
include how to handle risk of bias assessment from prior
reviews that are based on different tools from those used
in a new review. Lack of clear guidance in this area is a
barrier since the possible need to assess risk of bias for all
primary studies introduces resource demands that reduce
the likelihood of efficiency gains from incorporating exist-
ing systematic reviews.
Determining use: synthesis, including strength of evidence
assessment
Available guidance Cochrane and the EPC program
provide some guidance on using the synthesis from
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vides guidance on using prior synthesis in an update of a
review and in an overview of reviews. In an update,
Cochrane recommends rerunning the quantitative syn-
thesis if data from new studies are found. In an overview
of reviews, Cochrane recommends relying on the previ-
ous analysis as much as possible and only reanalyzing
data if necessary (for example, if different populations or
subgroups are analyzed in different reviews). The EPC
program recommends incorporating an existing review
in its entirety, including evidence summaries, only if it is
high quality, the key questions are very similar to the new
review’s questions, and the methods used are consistent
with EPC program methods. However, current EPC pro-
gram guidance does not explicitly address methods for
incorporating prior syntheses. The EPC program does
address dealing with discordant results from existing re-
views and recommends making an effort to determine
reasons for the disagreements both as part of the new
review planning and in discussion of its findings. At the
review planning stage, uncertainty of which discrepant
results to trust can provide a strong rationale for con-
ducting a new review. No current guidance is available
on performing strength of evidence assessments for sys-
tematic reviews, particularly as one component of a lar-
ger body of evidence answering a key question.
Evidence-based practice center discussions Most EPC
members had concerns over how and if you can trust a
prior review and whether or not you can trust the data
synthesis. The lack of guidance available for assessing
strength of evidence when integrating an existing system-
atic review into a new review poses particular challenges.
Despite current guidance, EPC members had additional
concerns about how to deal with discordant results from
reviews.
Assessment Limited guidance is available on using the
synthesis from existing reviews and this is an area that
EPC members struggle with when considering using
existing reviews. EPCs particularly struggle when asked
to assess overall strength of evidence for mixed bodies
of evidence (that is, those representing both primary
studies and prior systematic reviews). The difficulty is
compounded by the need for different guidance, depend-
ing on the circumstances surrounding the prior review
(s) and the current review. We identified four scenarios
that might require different guidance as to how the syn-
thesis may be used from an existing review: 1) up-to-date
and has a meta-analysis; 2) up-to-date and presents a nar-
rative summary; 3) not up-to-date and has a meta-analysis;
and 4) not up-to-date and presents a narrative summary.
These scenarios obviously apply only when one or more
existing reviews are being included in a new review basedon meeting certain criteria (for example, scope of key
questions, PICOTS, and quality).
Methods and results reporting
Available guidance IQWiG, NICE, Cochrane and the
EPC program present guidance on reporting results
when utilizing existing reviews (see Table 3). The Annals
of Internal Medicine has also published methodological
reporting requirements for authors [19]. For a benefit
assessment based on systematic reviews, IQWiG recom-
mends summarizing the results from existing reviews in
tables and noting any differences in results between re-
views. In a guideline document using existing reviews,
NICE recommends referencing evidence tables from exist-
ing guidelines with a direct link to the source. Cochrane
provides guidance on how to present information in an
update of a review, including how to highlight information
from new studies. When integrating existing reviews, the
EPC program recommends including a summary table of
included systematic reviews, including an assessment of
the overlap in primary studies between reviews. Addition-
ally, the EPC program recommends justifying the use of
existing reviews in a new review and commenting on ad-
vantages and disadvantages of using existing reviews in
the discussion session. In an update of a review, the EPC
program recommends explicitly showing what has chan-
ged from the previous report.
Evidence-based practice center discussions EPC mem-
bers had concerns about how to show evidence from re-
views, including how to highlight the primary evidence
when using a prior review. Challenges have surfaced
when users of EPC reports are unable to identify specific
details about primary studies because they have been
included as a part of a systematic review instead of
highlighted individually. Some EPC members have pre-
sented varying levels of detail based on how they used
existing reviews but had no guidance on the best ap-
proaches. Other EPC members have presented existing
systematic reviews in tables and pulled out elements for
discussion, even when the existing reviews are not other-
wise integrated into a report.
Assessment While some guidance is available for how
to report the methods to locate and decide how to use
an existing review, issues still may arise when reporting
results from existing reviews. Specifically, it can be diffi-
cult to highlight primary studies or isolate results from
individual studies when integrating results from existing
reviews. It is also important to not double count studies,
such as through inclusion of primary studies also in-
cluded in existing systematic reviews or by considering
as separate evidence systematic reviews with overlapping
primary studies. Guidance is needed on the level of
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incorporated into evidence tables. Future examination of
various approaches recommended by different groups
and development of a set of templates with worked ex-
amples could be very useful.Conclusions
It is considered good practice in research to explicitly
consider what is already known. Specifically, there is also
increased pressure to use existing systematic reviews in
new reviews to leverage work already completed and
thus, theoretically, reduce the amount of resources
needed. Starting a new systematic review is resource-
intensive, but it is unclear if the benefits of incorporating
existing systematic reviews into new reviews are in some
ways aspirational. This is perhaps in part because of the
lack of methods for doing so.
Our workgroup was formed as part of the methods
work of the AHRQ EPC program and we focused on
systematic reviews of health questions. Challenges in
using existing systematic reviews in new reviews, and
the options to address these challenges, may differ for
different kinds of systematic reviews. We would suggest
that examining whether our recommendations apply in
these other contexts is an area for future work. How-
ever, we feel that the concepts raised and discussed here
are broadly applicable to systematic reviews in general.Table 4 Guidance recommendations for methodological areas
Methodological area Guidance status Recomme





Assessing relevance Guidance exists Follow cu
Assessing review quality Current tools, such as AMSTAR, have
limitations and none consider primary




Scanning references Guidance exists Follow cu
Search strategy/results
of existing searches
Guidance exists Empiric ev
excluded
Data abstraction Current guidance is limited Guidance
abstracted
Study-level risk of bias
assessments
Guidance available for primary studies Guidance
reviews






AMSTAR, A Measurement Tool to Assess Systematic Reviews; EPC, Evidence-based PThere is consensus among health-focused systematic
review organizations and the EPCs about some as-
pects of incorporating existing systematic reviews into
new reviews. Best practice requires a discussion of
existing systematic reviews in the introduction and
discussion sections of any new review. In all reviews,
it is important to discuss how the current systematic
review conclusions concur or differ from previous re-
views. There remain, however, challenges for review
authors attempting to incorporate existing systematic
reviews into new systematic reviews. The methodo-
logical steps of using existing systematic reviews, sta-
tus of existing guidance, and our recommendations
are summarized in Table 4.
Remaining areas of uncertainty may be addressed
through a variety of methods. For instance, how best
to construct evidence tables that combine primary
studies and evidence from existing reviews may be
addressed through discussions with end users of sys-
tematic reviews. Methods research could assess the
minimum quality control needed for using prior data
abstractions or the impact on conclusions of a search
of systematic reviews limited to specific sources.
Finally, a symposium of systematic review organiza-
tions may be needed to develop consensus on reporting
standards for communicating how prior reviews are incor-
porated. Future EPC program workgroups are taking up
this challenge.in using existing systematic reviews
ndations/Further work needed
arch to locate only highly relevant, well-done, very recent, existing
onsider narrowing further to specific sources like EPC or Cochrane.
udy of comprehensive versus limited consideration of specific sources
arranted. Consider how much documentation of search strategies and
quired for transparency.
rrent guidance
idence of quality rating approaches is needed. Consider which currently
or soon to be available) tools best fit the EPC program’s needs.
rrent guidance
idence for considering searches from >1 review and considering
studies is needed
needed for specific scenarios and for confirming accuracy of
data
is needed for when to accept or repeat assessments from existing
needed for specific scenarios and for assessing strength of evidence
grating existing review
needed on level of detail necessary for all aspects, and options with
amples needed for evidence tables
ractice Center.
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